Abstract
Regulatory T cells (Treg) play an indispensable role in maintaining the body’s immune nonresponse to self-antigens and suppressing the body’s unwarranted and potentially harmful immune responses. Their absence, reduction, dysfunction, transformation, and instability can lead to numerous autoimmune diseases. There are several distinct subtypes of the Treg cells, although they share certain biological characteristics and have unique phenotypes with different regulatory functions, as well as mechanistic abilities. In this book chapter, we introduce the latest advances in Treg cell subtypes pertaining to classification, phenotype, biological characteristics, and mechanisms. We also highlight the relationship between Treg cells and various diseases, including autoimmune, infectious, as well as tumors and organ transplants.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agostini L, Martinon F, Burns K, McDermott MF, Hawkins PN, Tschopp J (2004) NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 20(3):319–325. https://doi.org/10.1016/s1074-7613(04)00046-9
Akimova T, Beier UH, Wang L, Levine MH, Hancock WW (2011) Helios expression is a marker of T cell activation and proliferation. PLoS One 6(8):e24226. https://doi.org/10.1371/journal.pone.0024226
Anna Maria Wolf DW et al (2002) Increase of regulatory T Cells in the peripheral blood of cancer patients. Clin Cancer Res 9:606–612
Artlett CM, Black CM, Briggs DC, Stevens CO, Welsh KI (1996) Telomere reduction in scleroderma patients: a possible cause for chromosomal instability. Br J Rheumatol 35(8):732–737. https://doi.org/10.1093/rheumatology/35.8.732
Atif M, Conti F, Gorochov G, Oo YH, Miyara M (2020) Regulatory T cells in solid organ transplantation. Clin Transl Immunol 9(2):e01099. https://doi.org/10.1002/cti2.1099
Awasthi A, Carrier Y, Peron JP, Bettelli E, Kamanaka M, Flavell RA, Kuchroo VK, Oukka M, Weiner HL (2007) A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat Immunol 8(12):1380–1389. https://doi.org/10.1038/ni1541
Bacchetta R, de Waal Malefijt R, Yssel H, Abrams J, de Vries JE, Spits H, Roncarolo MG (1990) Host-reactive CD4+ and CD8+ T cell clones isolated from a human chimera produce IL-5, IL-2, IFN-gamma and granulocyte/macrophage-colony-stimulating factor but not IL-4. J Immunol 144(3):902–908
Bacchetta R, Bigler M, Touraine JL, Parkman R, Tovo PA, Abrams J, de Waal Malefyt R, de Vries JE, Roncarolo MG (1994) High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J Exp Med 179(2):493–502. https://doi.org/10.1084/jem.179.2.493
Bacchetta R, Barzaghi F, Roncarolo MG (2018) From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation. Ann N Y Acad Sci 1417(1):5–22. https://doi.org/10.1111/nyas.13011
Bahmani B, Uehara M, Jiang L, Ordikhani F, Banouni N, Ichimura T, Solhjou Z, Furtmüller GJ, Brandacher G, Alvarez D, von Andrian UH, Uchimura K, Xu Q, Vohra I, Yilmam OA, Haik Y, Azzi J, Kasinath V, Bromberg JS, McGrath MM, Abdi R (2018) Targeted delivery of immune therapeutics to lymph nodes prolongs cardiac allograft survival. J Clin Invest 128(11):4770–4786. https://doi.org/10.1172/jci120923
Bates GJ, Fox SB, Han C, Leek RD, Garcia JF, Harris AL, Banham AH (2006) Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. J Clin Oncol 24(34):5373–5380. https://doi.org/10.1200/jco.2006.05.9584
Batten M, Kljavin NM, Li J, Walter MJ, de Sauvage FJ, Ghilardi N (2008) Cutting edge: IL-27 is a potent inducer of IL-10 but not FoxP3 in murine T cells. J Immunol 180(5):2752–2756. https://doi.org/10.4049/jimmunol.180.5.2752
Baeten D et al (2006) Phenotypically and functionally distinct CD8+ lymphocyte populations in long-term drug-free tolerance and chronic rejection in human kidney graft recipients. J Am Soc Nephrol 17(1):294–304
Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL (2002) CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420(6915):502–507. https://doi.org/10.1038/nature01152
Belkaid Y, Blank RB, Suffia I (2006) Natural regulatory T cells and parasites: a common quest for host homeostasis. Immunol Rev 212:287–300. https://doi.org/10.1111/j.0105-2896.2006.00409.x
Boesteanu AC, Katsikis PD (2009) Memory T cells need CD28 costimulation to remember. Semin Immunol 21(2):69–77. https://doi.org/10.1016/j.smim.2009.02.005
Borthwick NJ, Lowdell M, Salmon M, Akbar AN (2000) Loss of CD28 expression on CD8(+) T cells is induced by IL-2 receptor gamma chain signalling cytokines and type I IFN, and increases susceptibility to activation-induced apoptosis. Int Immunol 12(7):1005–1013. https://doi.org/10.1093/intimm/12.7.1005
Braud VM, Allan DS, McMichael AJ (1999) Functions of nonclassical MHC and non-MHC-encoded class I molecules. Curr Opin Immunol 11(1):100–108
Brun V, Bastian H, Neveu V, Foussat A (2009) Clinical grade production of IL-10 producing regulatory Tr1 lymphocytes for cell therapy of chronic inflammatory diseases. Int Immunopharmacol 9(5):609–613. https://doi.org/10.1016/j.intimp.2009.01.032
Brun V, Neveu V, Pers YM, Fabre S, Quatannens B, Bastian H, Clerget-Chossat N, Jorgensen C, Foussat A (2011) Isolation of functional autologous collagen-II specific IL-10 producing Tr1 cell clones from rheumatoid arthritis blood. Int Immunopharmacol 11(8):1074–1078. https://doi.org/10.1016/j.intimp.2011.03.001
Brunstein CG, Miller JS, Cao Q, McKenna DH, Hippen KL, Curtsinger J, Defor T, Levine BL, June CH, Rubinstein P, McGlave PB, Blazar BR, Wagner JE (2011) Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood 117(3):1061–1070. https://doi.org/10.1182/blood-2010-07-293795
Brunstein CG, Miller JS, McKenna DH, Hippen KL, DeFor TE, Sumstad D, Curtsinger J, Verneris MR, MacMillan ML, Levine BL, Riley JL, June CH, Le C, Weisdorf DJ, McGlave PB, Blazar BR, Wagner JE (2016) Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect. Blood 127(8):1044–1051. https://doi.org/10.1182/blood-2015-06-653667
Cabrera R, Tu Z, Xu Y, Firpi RJ, Rosen HR, Liu C, Nelson DR (2004) An immunomodulatory role for CD4(+) CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology 40(5):1062–1071. https://doi.org/10.1002/hep.20454
Cao D, van Vollenhoven R, Klareskog L, Trollmo C, Malmstrom V (2004) CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res Ther 6(4):R335–R346. https://doi.org/10.1186/ar1192
Cepek KL, Shaw SK, Parker CM, Russell GJ, Morrow JS, Rimm DL, Brenner MB (1994) Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the alpha E beta 7 integrin. Nature 372(6502):190–193. https://doi.org/10.1038/372190a0
Chandran S, Tang Q, Sarwal M, Laszik ZG, Putnam AL, Lee K, Leung J, Nguyen V, Sigdel T, Tavares EC, Yang JYC, Hellerstein M, Fitch M, Bluestone JA, Vincenti F (2017) Polyclonal regulatory T cell therapy for control of inflammation in kidney transplants. Am J Transplant 17(11):2945–2954. https://doi.org/10.1111/ajt.14415
Chang KM (2007) Regulatory T cells in hepatitis C virus infection. Hepatol Res 37(Suppl 3):S327–S330. https://doi.org/10.1111/j.1872-034X.2007.00220.x
Chen X, Priatel JJ, Chow MT, Teh HS (2008) Preferential development of CD4 and CD8 T regulatory cells in RasGRP1-deficient mice. J Immunol 180(9):5973–5982. https://doi.org/10.4049/jimmunol.180.9.5973
Chen M, Su W, Lin X, Guo Z, Wang J, Zhang Q, Brand D, Ryffel B, Huang J, Liu Z, He X, Le AD, Zheng SG (2013) Adoptive transfer of human gingiva-derived mesenchymal stem cells ameliorates collagen-induced arthritis via suppression of Th1 and Th17 cells and enhancement of regulatory T cell differentiation. Arthritis Rheum 65(5):1181–1193. https://doi.org/10.1002/art.37894
Cohen S, Janicki-Deverts D, Turner RB, Casselbrant ML, Li-Korotky HS, Epel ES, Doyle WJ (2013) Association between telomere length and experimentally induced upper respiratory viral infection in healthy adults. JAMA 309(7):699–705. https://doi.org/10.1001/jama.2013.613
Colmegna I, Diaz-Borjon A, Fujii H, Schaefer L, Goronzy JJ, Weyand CM (2008) Defective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritis. Arthritis Rheum 58(4):990–1000. https://doi.org/10.1002/art.23287
Costa DL, Guimaraes LH, Cardoso TM, Queiroz A, Lago E, Roselino AM, Bacellar O, Carvalho EM, Silva JS (2013) Characterization of regulatory T cell (Treg) function in patients infected with Leishmania braziliensis. Hum Immunol 74(12):1491–1500. https://doi.org/10.1016/j.humimm.2013.08.269
Dai H, Wan N, Zhang S, Moore Y, Wan F, Dai Z (2010) Cutting edge: programmed death-1 defines CD8+CD122+ T cells as regulatory versus memory T cells. J Immunol 185(2):803–807. https://doi.org/10.4049/jimmunol.1000661
Dai Z, Zhang S, Xie Q, Wu S, Su J, Li S, Xu Y, Li XC (2014) Natural CD8+CD122+ T cells are more potent in suppression of allograft rejection than CD4+CD25+ regulatory T cells. Am J Transplant 14(1):39–48. https://doi.org/10.1111/ajt.12515
de Waal Malefyt R, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor C, Johnson K, Kastelein R, Yssel H, de Vries JE (1991) Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 174(4):915–924. https://doi.org/10.1084/jem.174.4.915
Dinesh RK, Skaggs BJ, La Cava A, Hahn BH, Singh RP (2010) CD8+ Tregs in lupus, autoimmunity, and beyond. Autoimmun Rev 9(8):560–568. https://doi.org/10.1016/j.autrev.2010.03.006
Dulic S, Vasarhelyi Z, Bajnok A, Szalay B, Toldi G, Kovacs L, Balog A (2018) The impact of anti-TNF therapy on CD4+ and CD8+ cell subsets in ankylosing spondylitis. Pathobiology 85(3):201–210. https://doi.org/10.1159/000484250
Effros RB (2011) Telomere/telomerase dynamics within the human immune system: effect of chronic infection and stress. Exp Gerontol 46(2–3):135–140. https://doi.org/10.1016/j.exger.2010.08.027
Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, Isenberg DA, Mauri C (2004) Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med 200(3):277–285. https://doi.org/10.1084/jem.20040165
El-Asady R, Yuan R, Liu K, Wang D, Gress RE, Lucas PJ, Drachenberg CB, Hadley GA (2005) TGF-{beta}-dependent CD103 expression by CD8(+) T cells promotes selective destruction of the host intestinal epithelium during graft-versus-host disease. J Exp Med 201(10):1647–1657. https://doi.org/10.1084/jem.20041044
Endharti AT, Rifa IM, Shi Z, Fukuoka Y, Nakahara Y, Kawamoto Y, Takeda K, Isobe K, Suzuki H (2005) Cutting edge: CD8+CD122+ regulatory T cells produce IL-10 to suppress IFN-gamma production and proliferation of CD8+ T cells. J Immunol 175(11):7093–7097. https://doi.org/10.4049/jimmunol.175.11.7093
Endharti AT, Okuno Y, Shi Z, Misawa N, Toyokuni S, Ito M, Isobe K, Suzuki H (2011) CD8+CD122+ regulatory T cells (Tregs) and CD4+ Tregs cooperatively prevent and cure CD4+ cell-induced colitis. J Immunol 186(1):41–52. https://doi.org/10.4049/jimmunol.1000800
Esensten JH, Muller YD, Bluestone JA, Tang Q (2018) Regulatory T-cell therapy for autoimmune and autoinflammatory diseases: the next frontier. J Allergy Clin Immunol 142(6):1710–1718. https://doi.org/10.1016/j.jaci.2018.10.015
Fanchiang SS et al (2012) Global expression profiling of peripheral Qa-1-restricted CD8alphaalpha+TCRalphabeta+ regulatory T cells reveals innate-like features: implications for immune-regulatory repertoire. Hum Immunol 73(3):214–222
Fenoglio D, Ferrera F, Fravega M, Balestra P, Battaglia F, Proietti M, Andrei C, Olive D, Antonio LC, Indiveri F, Filaci G (2008) Advancements on phenotypic and functional characterization of non-antigen-specific CD8+CD28- regulatory T cells. Hum Immunol 69(11):745–750. https://doi.org/10.1016/j.humimm.2008.08.282
Fenoglio D, Battaglia F, Parodi A, Stringara S, Negrini S, Panico N, Rizzi M, Kalli F, Conteduca G, Ghio M, De Palma R, Indiveri F, Filaci G (2011) Alteration of Th17 and Treg cell subpopulations co-exist in patients affected with systemic sclerosis. Clin Immunol 139(3):249–257. https://doi.org/10.1016/j.clim.2011.01.013
Ferrer IR, Hester J, Bushell A, Wood KJ (2014) Induction of transplantation tolerance through regulatory cells: from mice to men. Immunol Rev 258(1):102–116. https://doi.org/10.1111/imr.12158
Fitzgerald DC, Zhang GX, El-Behi M, Fonseca-Kelly Z, Li H, Yu S, Saris CJ, Gran B, Ciric B, Rostami A (2007) Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat Immunol 8(12):1372–1379. https://doi.org/10.1038/ni1540
Flores-Borja F, Jury EC, Mauri C, Ehrenstein MR (2008) Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis. Proc Natl Acad Sci U S A 105(49):19396–19401. https://doi.org/10.1073/pnas.0806855105
Focosi D, Bestagno M, Burrone O, Petrini M (2010) CD57+ T lymphocytes and functional immune deficiency. J Leukoc Biol 87(1):107–116. https://doi.org/10.1189/jlb.0809566
Fontenot JD, Gavin MA, Rudensky AY (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4(4):330–336. https://doi.org/10.1038/ni904
Frantz C, Auffray C, Avouac J, Allanore Y (2018) Regulatory T cells in systemic sclerosis. Front Immunol 9:2356. https://doi.org/10.3389/fimmu.2018.02356
Frisullo G et al (2010) CD8(+)Foxp3(+) T cells in peripheral blood of relapsing-remitting multiple sclerosis patients. Hum Immunol 71(5):437–441
Gagliani N, Magnani CF, Huber S, Gianolini ME, Pala M, Licona-Limon P, Guo B, Herbert DR, Bulfone A, Trentini F, Di Serio C, Bacchetta R, Andreani M, Brockmann L, Gregori S, Flavell RA, Roncarolo MG (2013) Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nat Med 19(6):739–746. https://doi.org/10.1038/nm.3179
Gershon RK, Kondo K (1970) Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology 18(5):723–737
Gershon RK, Kondo K (1971) Infectious immunological tolerance. Immunology 21(6):903–914
Gershon RK, Cohen P, Hencin R, Liebhaber SA (1972) Suppressor T cells. J Immunol 108(3):586–590
Gianfrani C, Levings MK, Sartirana C, Mazzarella G, Barba G, Zanzi D, Camarca A, Iaquinto G, Giardullo N, Auricchio S, Troncone R, Roncarolo MG (2006) Gliadin-specific type 1 regulatory T cells from the intestinal mucosa of treated celiac patients inhibit pathogenic T cells. J Immunol 177(6):4178–4186. https://doi.org/10.4049/jimmunol.177.6.4178
Giovannetti A, Rosato E, Renzi C, Maselli A, Gambardella L, Giammarioli AM, Palange P, Paoletti P, Pisarri S, Salsano F, Malorni W, Pierdominici M (2010) Analyses of T cell phenotype and function reveal an altered T cell homeostasis in systemic sclerosis. Correlations with disease severity and phenotypes. Clin Immunol 137(1):122–133. https://doi.org/10.1016/j.clim.2010.06.004
Globinska A, Boonpiyathad T, Satitsuksanoa P, Kleuskens M, van de Veen W, Sokolowska M, Akdis M (2018) Mechanisms of allergen-specific immunotherapy: diverse mechanisms of immune tolerance to allergens. Ann Allergy Asthma Immunol 121(3):306–312. https://doi.org/10.1016/j.anai.2018.06.026
Godfrey VL, Wilkinson JE, Rinchik EM, Russell LB (1991) Fatal lymphoreticular disease in the scurfy (sf) mouse requires T cells that mature in a sf thymic environment: potential model for thymic education. Proc Natl Acad Sci U S A 88(13):5528–5532. https://doi.org/10.1073/pnas.88.13.5528
Goschl L, Scheinecker C, Bonelli M (2019) Treg cells in autoimmunity: from identification to Treg-based therapies. Semin Immunopathol 41(3):301–314. https://doi.org/10.1007/s00281-019-00741-8
Goudy K, Aydin D, Barzaghi F, Gambineri E, Vignoli M, Ciullini Mannurita S, Doglioni C, Ponzoni M, Cicalese MP, Assanelli A, Tommasini A, Brigida I, Dellepiane RM, Martino S, Olek S, Aiuti A, Ciceri F, Roncarolo MG, Bacchetta R (2013) Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity. Clin Immunol 146(3):248–261. https://doi.org/10.1016/j.clim.2013.01.004
Graca L, Cobbold SP, Waldmann H (2002) Identification of regulatory T cells in tolerated allografts. J Exp Med 195(12):1641–1646. https://doi.org/10.1084/jem.20012097
Grant CR, Liberal R, Mieli-Vergani G, Vergani D, Longhi MS (2015) Regulatory T-cells in autoimmune diseases: challenges, controversies and--yet--unanswered questions. Autoimmun Rev 14(2):105–116. https://doi.org/10.1016/j.autrev.2014.10.012
Gregori S, Roncarolo MG (2018) Engineered T regulatory type 1 cells for clinical application. Front Immunol 9:233. https://doi.org/10.3389/fimmu.2018.00233
Gregori S, Goudy KS, Roncarolo MG (2012) The cellular and molecular mechanisms of immuno-suppression by human type 1 regulatory T cells. Front Immunol 3:30. https://doi.org/10.3389/fimmu.2012.00030
Groux H, O’Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, Roncarolo MG (1997) A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389(6652):737–742. https://doi.org/10.1038/39614
Gu J, Lu L, Chen M, Xu L, Lan Q, Li Q, Liu Z, Chen G, Wang P, Wang X, Brand D, Olsen N, Zheng SG (2014) TGF-β-induced CD4+Foxp3+ T cells attenuate acute graft-versus-host disease by suppressing expansion and killing of effector CD8+ cells. J Immunol 193(7):3388–3397. https://doi.org/10.4049/jimmunol.1400207
Guillonneau C, Hill M, Hubert FX, Chiffoleau E, Herve C, Li XL, Heslan M, Usal C, Tesson L, Menoret S, Saoudi A, Le Mauff B, Josien R, Cuturi MC, Anegon I (2007) CD40Ig treatment results in allograft acceptance mediated by CD8CD45RC T cells, IFN-gamma, and indoleamine 2,3-dioxygenase. J Clin Invest 117(4):1096–1106. https://doi.org/10.1172/jci28801
Guo H, Zheng M, Zhang K, Yang F, Zhang X, Han Q, Chen ZN, Zhu P (2016) Functional defects in CD4(+) CD25(high) FoxP3(+) regulatory cells in ankylosing spondylitis. Sci Rep 6:37559. https://doi.org/10.1038/srep37559
Hadley GA, Bartlett ST, Via CS, Rostapshova EA, Moainie S (1997) The epithelial cell-specific integrin, CD103 (alpha E integrin), defines a novel subset of alloreactive CD8+ CTL. J Immunol 159(8):3748–3756
Hadley GA, Charandee C, Weir MR, Wang D, Bartlett ST, Drachenberg CB (2001) CD103+ CTL accumulate within the graft epithelium during clinical renal allograft rejection. Transplantation 72(9):1548–1555. https://doi.org/10.1097/00007890-200111150-00013
Han GM, O’Neil-Andersen NJ, Zurier RB, Lawrence DA (2008) CD4+CD25high T cell numbers are enriched in the peripheral blood of patients with rheumatoid arthritis. Cell Immunol 253(1–2):92–101. https://doi.org/10.1016/j.cellimm.2008.05.007
Haque A, Best SE, Amante FH, Mustafah S, Desbarrieres L, de Labastida F, Sparwasser T, Hill GR, Engwerda CR (2010) CD4+ natural regulatory T cells prevent experimental cerebral malaria via CTLA-4 when expanded in vivo. PLoS Pathog 6(12):e1001221. https://doi.org/10.1371/journal.ppat.1001221
Haque S, Rakieh C, Marriage F, Ho P, Gorodkin R, Teh LS, Snowden N, Day PJ, Bruce IN (2013) Shortened telomere length in patients with systemic lupus erythematosus. Arthritis Rheum 65(5):1319–1323. https://doi.org/10.1002/art.37895
Hartemann A, Bensimon G, Payan CA, Jacqueminet S, Bourron O, Nicolas N, Fonfrede M, Rosenzwajg M, Bernard C, Klatzmann D (2013) Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol 1(4):295–305. https://doi.org/10.1016/s2213-8587(13)70113-x
He J, Zhang X, Wei Y, Sun X, Chen Y, Deng J, Jin Y, Gan Y, Hu X, Jia R, Xu C, Hou Z, Leong YA, Zhu L, Feng J, An Y, Jia Y, Li C, Liu X, Ye H, Ren L, Li R, Yao H, Li Y, Chen S, Zhang X, Su Y, Guo J, Shen N, Morand EF, Yu D, Li Z (2016) Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosus. Nat Med 22(9):991–993. https://doi.org/10.1038/nm.4148
Ho J, Kurtz CC, Naganuma M, Ernst PB, Cominelli F, Rivera-Nieves J (2008) A CD8+/CD103high T cell subset regulates TNF-mediated chronic murine ileitis. J Immunol 180(4):2573–2580. https://doi.org/10.4049/jimmunol.180.4.2573
Honda M, Mengesha E, Albano S, Nichols WS, Wallace DJ, Metzger A, Klinenberg JR, Linker-Israeli M (2001) Telomere shortening and decreased replicative potential, contrasted by continued proliferation of telomerase-positive CD8+CD28(lo) T cells in patients with systemic lupus erythematosus. Clin Immunol 99(2):211–221. https://doi.org/10.1006/clim.2001.5023
Hori S, Carvalho TL, Demengeot J (2002) CD25+CD4+ regulatory T cells suppress CD4+ T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice. Eur J Immunol 32(5):1282–1291. https://doi.org/10.1002/1521-4141(200205)32:5<1282:Aid-immu1282>3.0.Co;2-#
Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299(5609):1057–1061. https://doi.org/10.1126/science.1079490
Horino S, Sasahara Y, Sato M, Niizuma H, Kumaki S, Abukawa D, Sato A, Imaizumi M, Kanegane H, Kamachi Y, Sasaki S, Terui K, Ito E, Kobayashi I, Ariga T, Tsuchiya S, Kure S (2014) Selective expansion of donor-derived regulatory T cells after allogeneic bone marrow transplantation in a patient with IPEX syndrome. Pediatr Transplant 18(1):E25–E30. https://doi.org/10.1111/petr.12184
Horwitz DA, Zheng SG, Gray JD (2008) Natural and TGF-beta-induced Foxp3(+) CD4(+) CD25(+) regulatory T cells are not mirror images of each other. Trends Immunol 29(9):429–435. https://doi.org/10.1016/j.it.2008.06.005
Horwitz DA, Pan S, Ou JN, Wang J, Chen M, Gray JD, Zheng SG (2013) Therapeutic polyclonal human CD8+ CD25+ Fox3+ TNFR2+ PD-L1+ regulatory cells induced ex-vivo. Clin Immunol 149(3):450–463. https://doi.org/10.1016/j.clim.2013.08.007
Huang W, Solouki S, Koylass N, Zheng SG, August A (2017) ITK signalling via the Ras/IRF4 pathway regulates the development and function of Tr1 cells. Nat Commun 8:15871. https://doi.org/10.1038/ncomms15871
Huang W, Solouki S, Carter C, Zheng SG, August A (2018) Beyond type 1 regulatory T cells: co-expression of LAG3 and CD49b in IL-10-producing T cell lineages. Front Immunol 9:2625. https://doi.org/10.3389/fimmu.2018.02625
Huber S, Gagliani N, Esplugues E, O’Connor W Jr, Huber FJ, Chaudhry A, Kamanaka M, Kobayashi Y, Booth CJ, Rudensky AY, Roncarolo MG, Battaglia M, Flavell RA (2011) Th17 cells express interleukin-10 receptor and are controlled by Foxp3(−) and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner. Immunity 34(4):554–565. https://doi.org/10.1016/j.immuni.2011.01.020
Humrich JY, von Spee-Mayer C, Siegert E, Alexander T, Hiepe F, Radbruch A, Burmester GR, Riemekasten G (2015) Rapid induction of clinical remission by low-dose interleukin-2 in a patient with refractory SLE. Ann Rheum Dis 74(4):791–792. https://doi.org/10.1136/annrheumdis-2014-206506
Ichihara F, Kono K, Takahashi A, Kawaida H, Sugai H, Fujii H (2003) Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. Clin Cancer Res 9:4404–4408
Iikuni N, Lourenço EV, Hahn BH, La Cava A (2009) Cutting edge: regulatory T cells directly suppress B cells in systemic lupus erythematosus. J Immunol 183 (3):1518–1522. doi:https://doi.org/10.4049/jimmunol.0901163
Issa F, Robb RJ, Wood KJ (2013) The where and when of T cell regulation in transplantation. Trends Immunol 34(3):107–113. https://doi.org/10.1016/j.it.2012.11.003
Itoh M, Takahashi T, Sakaguchi N, Kuniyasu Y, Shimizu J, Otsuka F, Sakaguchi S (1999) Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol 162(9):5317–5326
Iwasaki Y, Fujio K, Okamura T, Yanai A, Sumitomo S, Shoda H, Tamura T, Yoshida H, Charnay P, Yamamoto K (2013) Egr-2 transcription factor is required for Blimp-1-mediated IL-10 production in IL-27-stimulated CD4+ T cells. Eur J Immunol 43(4):1063–1073. https://doi.org/10.1002/eji.201242942
Jacob N, Yang H, Pricop L, Liu Y, Gao X, Zheng SG, Wang J, Gao HX, Putterman C, Koss MN, Stohl W, Jacob CO (2009) Accelerated pathological and clinical nephritis in systemic lupus erythematosus-prone New Zealand Mixed 2328 mice doubly deficient in TNF receptor 1 and TNF receptor 2 via a Th17-associated pathway. J Immunol 182(4):2532–2541. https://doi.org/10.4049/jimmunol.0802948
Jarnicki AG, Conroy H, Brereton C, Donnelly G, Toomey D, Walsh K, Sweeney C, Leavy O, Fletcher J, Lavelle EC, Dunne P, Mills KH (2008) Attenuating regulatory T cell induction by TLR agonists through inhibition of p38 MAPK signaling in dendritic cells enhances their efficacy as vaccine adjuvants and cancer immunotherapeutics. J Immunol 180(6):3797–3806. https://doi.org/10.4049/jimmunol.180.6.3797
Jiao Z, Wang W, Jia R, Li J, You H, Chen L, Wang Y (2007) Accumulation of FoxP3-expressing CD4+CD25+ T cells with distinct chemokine receptors in synovial fluid of patients with active rheumatoid arthritis. Scand J Rheumatol 36(6):428–433. https://doi.org/10.1080/03009740701482800
Jofra T, Di Fonte R, Galvani G, Kuka M, Iannacone M, Battaglia M, Fousteri G (2018) Tr1 cell immunotherapy promotes transplant tolerance via de novo Tr1 cell induction in mice and is safe and effective during acute viral infection. Eur J Immunol 48(8):1389–1399. https://doi.org/10.1002/eji.201747316
Johanns TM, Ertelt JM, Rowe JH, Way SS (2010) Regulatory T cell suppressive potency dictates the balance between bacterial proliferation and clearance during persistent Salmonella infection. PLoS Pathog 6(8):e1001043. https://doi.org/10.1371/journal.ppat.1001043
Jordan MS, Boesteanu A, Reed AJ, Petrone AL, Holenbeck AE, Lerman MA, Naji A, Caton AJ (2001) Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat Immunol 2(4):301–306. https://doi.org/10.1038/86302
Josefowicz SZ, Lu LF, Rudensky AY (2012) Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol 30:531–564. https://doi.org/10.1146/annurev.immunol.25.022106.141623
Ju S, Qiu H, Zhou X, Zhu B, Lv X, Huang X, Li J, Zhang Y, Liu L, Ge Y, Johnson DE, Ju S, Shu Y (2009) CD13+CD4+CD25hi regulatory T cells exhibit higher suppressive function and increase with tumor stage in non-small cell lung cancer patients. Cell Cycle 8(16):2578–2585. https://doi.org/10.4161/cc.8.16.9302
Judge AD, Zhang X, Fujii H, Surh CD, Sprent J (2002) Interleukin 15 controls both proliferation and survival of a subset of memory-phenotype CD8(+) T cells. J Exp Med 196(7):935–946. https://doi.org/10.1084/jem.20020772
Kaech SM, Wherry EJ, Ahmed R (2002) Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol 2(4):251–262. https://doi.org/10.1038/nri778
Kalogerou A, Gelou E, Mountantonakis S, Settas L, Zafiriou E, Sakkas L (2005) Early T cell activation in the skin from patients with systemic sclerosis. Ann Rheum Dis 64(8):1233–1235. https://doi.org/10.1136/ard.2004.027094
Karecla PI, Bowden SJ, Green SJ, Kilshaw PJ (1995) Recognition of E-cadherin on epithelial cells by the mucosal T cell integrin alpha M290 beta 7 (alpha E beta 7). Eur J Immunol 25(3):852–856. https://doi.org/10.1002/eji.1830250333
Kashima Y, Nishii N, Tachinami H, Furusawa E, Nagai S, Harada H, Azuma M (2020) Orthotopic tongue squamous cell carcinoma (SCC) model exhibiting a different tumor-infiltrating T-cell status with margin-restricted CD8(+) T cells and regulatory T cell-dominance, compared to skin SCC. Biochem Biophys Res Commun 526(1):218–224. https://doi.org/10.1016/j.bbrc.2020.03.022
Kawashiri SY, Kawakami A, Okada A, Koga T, Tamai M, Yamasaki S, Nakamura H, Origuchi T, Ida H, Eguchi K (2011) CD4+CD25(high)CD127(low/-) Treg cell frequency from peripheral blood correlates with disease activity in patients with rheumatoid arthritis. J Rheumatol 38(12):2517–2521. https://doi.org/10.3899/jrheum.110283
Khattri R, Cox T, Yasayko SA, Ramsdell F (2003) An essential role for scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 4(4):337–342. https://doi.org/10.1038/ni909
Kikuchi J, Hashizume M, Kaneko Y, Yoshimoto K, Nishina N, Takeuchi T (2015) Peripheral blood CD4(+) CD25(+) CD127(low) regulatory T cells are significantly increased by tocilizumab treatment in patients with rheumatoid arthritis: increase in regulatory T cells correlates with clinical response. Arthritis Res Ther 17:10. https://doi.org/10.1186/s13075-015-0526-4
Kim Sh SH, Kaminker P, Campisi J (2002) Telomeres, aging and cancer: in search of a happy ending. Oncogene 21(4):503–511. https://doi.org/10.1038/sj.onc.1205077
Kim HJ, Wang X, Radfar S, Sproule TJ, Roopenian DC, Cantor H (2011) CD8+ T regulatory cells express the Ly49 Class I MHC receptor and are defective in autoimmune prone B6-Yaa mice. Proc Natl Acad Sci U S A 108(5):2010–2015. https://doi.org/10.1073/pnas.1018974108
Klein S, Kretz CC, Ruland V, Stumpf C, Haust M, Hartschuh W, Hartmann M, Enk A, Suri-Payer E, Oberle N, Krammer PH, Kuhn A (2011) Reduction of regulatory T cells in skin lesions but not in peripheral blood of patients with systemic scleroderma. Ann Rheum Dis 70(8):1475–1481. https://doi.org/10.1136/ard.2009.116525
Kleinewietfeld M, Manzel A, Titze J, Kvakan H, Yosef N, Linker RA, Muller DN, Hafler DA (2013) Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature 496(7446):518–522. https://doi.org/10.1038/nature11868
Koch SD, Uss E, van Lier RA, ten Berge IJ (2008) Alloantigen-induced regulatory CD8+CD103+ T cells. Hum Immunol 69(11):737–744. https://doi.org/10.1016/j.humimm.2008.08.281
Koch K, Koch N, Sandaradura de Silva U, Jung N, Schulze zur Wiesch J, Fatkenheuer G, Hartmann P, Romerio F, Lehmann C (2015) Increased frequency of CD49b/LAG-3(+) type 1 regulatory T cells in HIV-infected individuals. AIDS Res Hum Retrovir 31(12):1238–1246. https://doi.org/10.1089/aid.2014.0356
Kojima A, Prehn RT (1981) Genetic susceptibility to post-thymectomy autoimmune diseases in mice. Immunogenetics 14(1–2):15–27. https://doi.org/10.1007/bf00344296
Kong N, Lan Q, Chen M, Wang J, Shi W, Horwitz DA, Quesniaux V, Ryffel B, Liu Z, Brand D, Zou H, Zheng SG (2012a) Antigen-specific transforming growth factor β-induced Treg cells, but not natural Treg cells, ameliorate autoimmune arthritis in mice by shifting the Th17/Treg cell balance from Th17 predominance to Treg cell predominance. Arthritis Rheum 64(8):2548–2558. https://doi.org/10.1002/art.34513
Kong N, Lan Q, Su W, Chen M, Wang J, Yang Z, Park R, Dagliyan G, Conti PS, Brand D, Liu Z, Stohl W, Zou H, Zheng SG (2012b) Induced T regulatory cells suppress osteoclastogenesis and bone erosion in collagen-induced arthritis better than natural T regulatory cells. Ann Rheum Dis 71(9):1567–1572. https://doi.org/10.1136/annrheumdis-2011-201052
Korecka-Polak A et al (2011) Human peripheral blood CD8+ CD28- T cells of renal allograft recipients do not express FOXP3 protein. Transplant Proc 43(8):2917–2921
Krupnick AS, Lin X, Li W, Higashikubo R, Zinselmeyer BH, Hartzler H, Toth K, Ritter JH, Berezin MY, Wang ST, Miller MJ, Gelman AE, Kreisel D (2014) Central memory CD8+ T lymphocytes mediate lung allograft acceptance. J Clin Invest 124(3):1130–1143. https://doi.org/10.1172/jci71359
Ku CC et al (2000) Control of homeostasis of CD8+ memory T cells by opposing cytokines. Science 288(5466):675–678
Lanteri MC, O’Brien KM, Purtha WE, Cameron MJ, Lund JM, Owen RE, Heitman JW, Custer B, Hirschkorn DF, Tobler LH, Kiely N, Prince HE, Ndhlovu LC, Nixon DF, Kamel HT, Kelvin DJ, Busch MP, Rudensky AY, Diamond MS, Norris PJ (2009) Tregs control the development of symptomatic West Nile virus infection in humans and mice. J Clin Invest 119(11):3266–3277. https://doi.org/10.1172/jci39387
Lars A, Ormandy TH, Wedemeyer H, Manns MP, Greten TF, Korangy F (2005) Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. Cancer Res 65:6
Layland LE, Straubinger K, Ritter M, Loffredo-Verde E, Garn H, Sparwasser T, Prazeres da Costa C (2013) Schistosoma mansoni-mediated suppression of allergic airway inflammation requires patency and Foxp3+ Treg cells. PLoS Negl Trop Dis 7(8):e2379. https://doi.org/10.1371/journal.pntd.0002379
Lee HM, Hsieh CS (2009) Rare development of Foxp3+ thymocytes in the CD4+CD8+ subset. J Immunol 183(4):2261–2266. https://doi.org/10.4049/jimmunol.0901304
Lee I, Wang L, Wells AD, Dorf ME, Ozkaynak E, Hancock WW (2005) Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J Exp Med 201(7):1037–1044. https://doi.org/10.1084/jem.20041709
Lee YH, Ishida Y, Rifa'i M, Shi Z, Isobe K, Suzuki H (2008) Essential role of CD8+CD122+ regulatory T cells in the recovery from experimental autoimmune encephalomyelitis. J Immunol 180(2):825–832. https://doi.org/10.4049/jimmunol.180.2.825
Lerret NM, Houlihan JL, Kheradmand T, Pothoven KL, Zhang ZJ, Luo X (2012) Donor-specific CD8+ Foxp3+ T cells protect skin allografts and facilitate induction of conventional CD4+ Foxp3+ regulatory T cells. Am J Transplant 12(9):2335–2347. https://doi.org/10.1111/j.1600-6143.2012.04120.x
Levings MK, Gregori S, Tresoldi E, Cazzaniga S, Bonini C, Roncarolo MG (2005) Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells. Blood 105(3):1162–1169. https://doi.org/10.1182/blood-2004-03-1211
Liang S, Alard P, Zhao Y, Parnell S, Clark SL, Kosiewicz MM (2005) Conversion of CD4+ CD25- cells into CD4+ CD25+ regulatory T cells in vivo requires B7 costimulation, but not the thymus. J Exp Med 201(1):127–137. https://doi.org/10.1084/jem.20041201
Liao HT, Lin YF, Tsai CY, Chou CT (2015) Regulatory T cells in ankylosing spondylitis and the response after adalimumab treatment. Joint Bone Spine 82(6):423–427. https://doi.org/10.1016/j.jbspin.2015.03.003
Liao T, Xue Y, Zhao D, Li S, Liu M, Chen J, Brand DD, Zheng H, Zhang Y, Zheng SG, Sun Q (2017) In vivo attenuation of antibody-mediated acute renal allograft rejection by ex vivo TGF-β-induced CD4(+)Foxp3(+) regulatory T cells. Front Immunol 8:1334. https://doi.org/10.3389/fimmu.2017.01334
Lin X, Chen M, Liu Y, Guo Z, He X, Brand D, Zheng SG (2013) Advances in distinguishing natural from induced Foxp3(+) regulatory T cells. Int J Clin Exp Pathol 6(2):116–123
Lina C, Conghua W, Nan L, Ping Z (2011) Combined treatment of etanercept and MTX reverses Th1/Th2, Th17/Treg imbalance in patients with rheumatoid arthritis. J Clin Immunol 31(4):596–605. https://doi.org/10.1007/s10875-011-9542-6
Liu X, Gao N, Li M, Xu D, Hou Y, Wang Q, Zhang G, Sun Q, Zhang H, Zeng X (2013a) Elevated levels of CD4(+)CD25(+)FoxP3(+) T cells in systemic sclerosis patients contribute to the secretion of IL-17 and immunosuppression dysfunction. PLoS One 8(6):e64531. https://doi.org/10.1371/journal.pone.0064531
Liu Z, Fan H, Jiang S (2013b) CD4(+) T-cell subsets in transplantation. Immunol Rev 252(1):183–191. https://doi.org/10.1111/imr.12038
Liu Y, Lan Q, Lu L, Chen M, Xia Z, Ma J, Wang J, Fan H, Shen Y, Ryffel B, Brand D, Quismorio F, Liu Z, Horwitz DA, Xu A, Zheng SG (2014) Phenotypic and functional characteristic of a newly identified CD8+ Foxp3- CD103+ regulatory T cells. J Mol Cell Biol 6(1):81–92. https://doi.org/10.1093/jmcb/mjt026
Liu H, Wang Y, Zeng Q, Zeng YQ, Liang CL, Qiu F, Nie H, Dai Z (2017) Suppression of allograft rejection by CD8+CD122+PD-1+ Tregs is dictated by their Fas ligand-initiated killing of effector T cells versus Fas-mediated own apoptosis. Oncotarget 8(15):24187–24195. https://doi.org/10.18632/oncotarget.15551
Liu H, Qiu F, Wang Y, Zeng Q, Liu C, Chen Y, Liang CL, Zhang Q, Han L, Dai Z (2019) CD8+CD122+PD-1+ Tregs synergize with costimulatory blockade of CD40/CD154, but not B7/CD28, to prolong murine allograft survival. Front Immunol 10:306. https://doi.org/10.3389/fimmu.2019.00306
Liyanage UK, Moore TT, Joo HG, Tanaka Y, Herrmann V, Doherty G, Drebin JA, Strasberg SM, Eberlein TJ, Goedegebuure PS, Linehan DC (2002) Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 169(5):2756–2761. https://doi.org/10.4049/jimmunol.169.5.2756
Lu L, Yu Y, Li G, Pu L, Zhang F, Zheng S, Wang X (2009) CD8(+) CD103(+) regulatory T cells in spontaneous tolerance of liver allografts. Int Immunopharmacol 9(5):546–548. https://doi.org/10.1016/j.intimp.2009.01.021
Lu L, Wang J, Zhang F, Chai Y, Brand D, Wang X, Horwitz DA, Shi W, Zheng SG (2010) Role of SMAD and non-SMAD signals in the development of Th17 and regulatory T cells. J Immunol 184(8):4295–4306. https://doi.org/10.4049/jimmunol.0903418
Lu L, Lan Q, Li Z, Zhou X, Gu J, Li Q, Wang J, Chen M, Liu Y, Shen Y, Brand DD, Ryffel B, Horwitz DA, Quismorio FP, Liu Z, Li B, Olsen NJ, Zheng SG (2014) Critical role of all-trans retinoic acid in stabilizing human natural regulatory T cells under inflammatory conditions. Proc Natl Acad Sci U S A 111(33):E3432–E3440
Lühn K, Simmons CP, Moran E, Dung NT, Chau TN, Quyen NT, Thao le TT, Van Ngoc T, Dung NM, Wills B, Farrar J, McMichael AJ, Dong T, Rowland-Jones S (2007) Increased frequencies of CD4+ CD25(high) regulatory T cells in acute dengue infection. J Exp Med 204(5):979–985. https://doi.org/10.1084/jem.20061381
Lund JM, Hsing L, Pham TT, Rudensky AY (2008) Coordination of early protective immunity to viral infection by regulatory T cells. Science 320(5880):1220–1224. https://doi.org/10.1126/science.1155209
Luo Y, Zheng SG (2016) Hall of fame among pro-inflammatory cytokines: interleukin-6 gene and its transcriptional regulation mechanisms. Front Immunol 7:604. https://doi.org/10.3389/fimmu.2016.00604
Luo Y, Xue Y, Wang J, Dang J, Fang Q, Huang G, Olsen N, Zheng SG (2019) Negligible effect of sodium chloride on the development and function of TGF-beta-induced CD4(+) Foxp3(+) regulatory T cells. Cell Rep 26(7):1869–1879 e1863. https://doi.org/10.1016/j.celrep.2019.01.066
Ma J, Yu J, Tao X, Cai L, Wang J, Zheng SG (2010) The imbalance between regulatory and IL-17-secreting CD4+ T cells in lupus patients. Clin Rheumatol 29(11):1251–1258. https://doi.org/10.1007/s10067-010-1510-7
Ma L, Simpson E, Li J, Xuan M, Xu M, Baker L, Shi Y, Yougbare I, Wang X, Zhu G, Chen P, Prud’homme GJ, Lazarus AH, Freedman J, Ni H (2015) CD8+ T cells are predominantly protective and required for effective steroid therapy in murine models of immune thrombocytopenia. Blood 126(2):247–256. https://doi.org/10.1182/blood-2015-03-635417
MacDonald KG, Dawson NA, Huang Q, Dunne JV, Levings MK, Broady R (2015) Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis. J Allergy Clin Immunol 135(4):946–9e9. https://doi.org/10.1016/j.jaci.2014.12.1932
Malek TR (2008) The biology of interleukin-2. Annu Rev Immunol 26:453–479. https://doi.org/10.1146/annurev.immunol.26.021607.090357
Manavalan JS et al (2004) Alloantigen specific CD8+CD28- FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity. Int Immunol 16(8):1055–1068
Mandapathil M, Szczepanski MJ, Szajnik M, Ren J, Jackson EK, Johnson JT, Gorelik E, Lang S, Whiteside TL (2010) Adenosine and prostaglandin E2 cooperate in the suppression of immune responses mediated by adaptive regulatory T cells. J Biol Chem 285(36):27571–27580. https://doi.org/10.1074/jbc.M110.127100
Mangalam AK, Luckey D, Giri S, Smart M, Pease LR, Rodriguez M, David CS (2012) Two discreet subsets of CD8 T cells modulate PLP (91-110) induced experimental autoimmune encephalomyelitis in HLA-DR3 transgenic mice. J Autoimmun 38(4):344–353. https://doi.org/10.1016/j.jaut.2012.02.004
Martín-Orozco E, Norte-Muñoz M, Martínez-García J (2017) Regulatory T cells in allergy and asthma. Front Pediatr 5:117. https://doi.org/10.3389/fped.2017.00117
Mascanfroni ID, Takenaka MC, Yeste A, Patel B, Wu Y, Kenison JE, Siddiqui S, Basso AS, Otterbein LE, Pardoll DM, Pan F, Priel A, Clish CB, Robson SC, Quintana FJ (2015) Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-alpha. Nat Med 21(6):638–646. https://doi.org/10.1038/nm.3868
Mathew JM, Voss JH, LeFever A, Konieczna I, Stratton C, He J, Huang X, Gallon L, Skaro A, Ansari MJ, Leventhal JR (2018) A phase I clinical trial with ex vivo expanded recipient regulatory T cells in living donor kidney transplants. Sci Rep 8(1):7428. https://doi.org/10.1038/s41598-018-25574-7
Mathian A, Parizot C, Dorgham K, Trad S, Arnaud L, Larsen M, Miyara M, Hié M, Piette JC, Frances C, Yssel H, Amoura Z, Gorochov G (2012) Activated and resting regulatory T cell exhaustion concurs with high levels of interleukin-22 expression in systemic sclerosis lesions. Ann Rheum Dis 71(7):1227–1234. https://doi.org/10.1136/annrheumdis-2011-200709
Maynard CL, Harrington LE, Janowski KM, Oliver JR, Zindl CL, Rudensky AY, Weaver CT (2007) Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10. Nat Immunol 8(9):931–941. https://doi.org/10.1038/ni1504
Meloni F, Solari N, Cavagna L, Morosini M, Montecucco CM, Fietta AM (2009) Frequency of Th1, Th2 and Th17 producing T lymphocytes in bronchoalveolar lavage of patients with systemic sclerosis. Clin Exp Rheumatol 27(5):765–772
Mempel TR, Bauer CA (2009) Intravital imaging of CD8+ T cell function in cancer. Clin Exp Metastasis 26(4):311–327. https://doi.org/10.1007/s10585-008-9196-9
Mikulkova Z, Praksova P, Stourac P, Bednarik J, Strajtova L, Pacasova R, Belobradkova J, Dite P, Michalek J (2010) Numerical defects in CD8+CD28- T-suppressor lymphocyte population in patients with type 1 diabetes mellitus and multiple sclerosis. Cell Immunol 262(2):75–79. https://doi.org/10.1016/j.cellimm.2010.02.002
Miller WP, Srinivasan S, Panoskaltsis-Mortari A, Singh K, Sen S, Hamby K, Deane T, Stempora L, Beus J, Turner A, Wheeler C, Anderson DC, Sharma P, Garcia A, Strobert E, Elder E, Crocker I, Crenshaw T, Penedo MC, Ward T, Song M, Horan J, Larsen CP, Blazar BR, Kean LS (2010) GVHD after haploidentical transplantation: a novel, MHC-defined rhesus macaque model identifies CD28- CD8+ T cells as a reservoir of breakthrough T-cell proliferation during costimulation blockade and sirolimus-based immunosuppression. Blood 116(24):5403–5418. https://doi.org/10.1182/blood-2010-06-289272
Mills KH (2004) Regulatory T cells: friend or foe in immunity to infection? Nat Rev Immunol 4(11):841–855. https://doi.org/10.1038/nri1485
Miyara M, Yoshioka Y, Kitoh A, Shima T, Wing K, Niwa A, Parizot C, Taflin C, Heike T, Valeyre D, Mathian A, Nakahata T, Yamaguchi T, Nomura T, Ono M, Amoura Z, Gorochov G, Sakaguchi S (2009) Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 30(6):899–911. https://doi.org/10.1016/j.immuni.2009.03.019
Mohr A, Atif M, Balderas R, Gorochov G, Miyara M (2019) The role of FOXP3(+) regulatory T cells in human autoimmune and inflammatory diseases. Clin Exp Immunol 197(1):24–35. https://doi.org/10.1111/cei.13288
Molloy MJ, Zhang W, Usherwood EJ (2011) Suppressive CD8+ T cells arise in the absence of CD4 help and compromise control of persistent virus. J Immunol 186(11):6218–6226. https://doi.org/10.4049/jimmunol.1003812
Montoya-Ortiz G (2013) Immunosenescence, aging, and systemic lupus erythematous. Autoimmune Dis 2013:267078. https://doi.org/10.1155/2013/267078
Moore AC, Gallimore A, Draper SJ, Watkins KR, Gilbert SC, Hill AV (2005) Anti-CD25 antibody enhancement of vaccine-induced immunogenicity: increased durable cellular immunity with reduced immunodominance. J Immunol 175(11):7264–7273. https://doi.org/10.4049/jimmunol.175.11.7264
Moreno-Fernandez ME, Rueda CM, Rusie LK, Chougnet CA (2011) Regulatory T cells control HIV replication in activated T cells through a cAMP-dependent mechanism. Blood 117(20):5372–5380. https://doi.org/10.1182/blood-2010-12-323162
Myers L, Croft M, Kwon BS, Mittler RS, Vella AT (2005) Peptide-specific CD8 T regulatory cells use IFN-gamma to elaborate TGF-beta-based suppression. J Immunol 174(12):7625–7632. https://doi.org/10.4049/jimmunol.174.12.7625
Nadkarni S, Mauri C, Ehrenstein MR (2007) Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta. J Exp Med 204(1):33–39. https://doi.org/10.1084/jem.20061531
Nagata T, Koide Y (2010) Induction of specific CD8 T cells against intracellular bacteria by CD8 T-cell-oriented immunization approaches. J Biomed Biotechnol 2010:764542. https://doi.org/10.1155/2010/764542
Niu Q, Cai B, Huang ZC, Shi YY, Wang LL (2012) Disturbed Th17/Treg balance in patients with rheumatoid arthritis. Rheumatol Int 32(9):2731–2736. https://doi.org/10.1007/s00296-011-1984-x
Noble A, Pestano GA, Cantor H (1998) Suppression of immune responses by CD8 cells. I. Superantigen-activated CD8 cells induce unidirectional Fas-mediated apoptosis of antigen-activated CD4 cells. J Immunol 160(2):559–565
O’Connor RA, Leech MD, Suffner J, Hämmerling GJ, Anderton SM (2010) Myelin-reactive, TGF-β-induced regulatory T cells can be programmed to develop Th1-like effector function but remain less proinflammatory than myelin-reactive Th1 effectors and can suppress pathogenic T cell clonal expansion in vivo. J Immunol 185(12):7235–7243. https://doi.org/10.4049/jimmunol.1001551
Ohkura N, Hamaguchi M, Morikawa H, Sugimura K, Tanaka A, Ito Y, Osaki M, Tanaka Y, Yamashita R, Nakano N, Huehn J, Fehling HJ, Sparwasser T, Nakai K, Sakaguchi S (2012) T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development. Immunity 37(5):785–799. https://doi.org/10.1016/j.immuni.2012.09.010
Oldenhove G, Bouladoux N, Wohlfert EA, Hall JA, Chou D, Dos Santos L, O’Brien S, Blank R, Lamb E, Natarajan S, Kastenmayer R, Hunter C, Grigg ME, Belkaid Y (2009) Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity 31(5):772–786. https://doi.org/10.1016/j.immuni.2009.10.001
Pandiyan P, Conti HR, Zheng L, Peterson AC, Mathern DR, Hernández-Santos N, Edgerton M, Gaffen SL, Lenardo MJ (2011) CD4(+) CD25(+) Foxp3(+) regulatory T cells promote Th17 cells in vitro and enhance host resistance in mouse Candida albicans Th17 cell infection model. Immunity 34(3):422–434. https://doi.org/10.1016/j.immuni.2011.03.002
Papp G, Horvath IF, Barath S, Gyimesi E, Sipka S, Szodoray P, Zeher M (2011) Altered T-cell and regulatory cell repertoire in patients with diffuse cutaneous systemic sclerosis. Scand J Rheumatol 40(3):205–210. https://doi.org/10.3109/03009742.2010.528021
Pauls K, Schon M, Kubitza RC, Homey B, Wiesenborn A, Lehmann P, Ruzicka T, Parker CM, Schon MP (2001) Role of integrin alphaE(CD103)beta7 for tissue-specific epidermal localization of CD8+ T lymphocytes. J Invest Dermatol 117(3):569–575. https://doi.org/10.1046/j.0022-202x.2001.01481.x
Pellegrino M, Crino A, Rosado MM, Fierabracci A (2019) Identification and functional characterization of CD8+ T regulatory cells in type 1 diabetes patients. PLoS One 14(1):e0210839. https://doi.org/10.1371/journal.pone.0210839
Piccirillo CA, Letterio JJ, Thornton AM, McHugh RS, Mamura M, Mizuhara H, Shevach EM (2002) CD4(+) CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness. J Exp Med 196(2):237–246. https://doi.org/10.1084/jem.20020590
Picker LJ, Terstappen LW, Rott LS, Streeter PR, Stein H, Butcher EC (1990) Differential expression of homing-associated adhesion molecules by T cell subsets in man. J Immunol 145(10):3247–3255
Pot C, Jin H, Awasthi A, Liu SM, Lai CY, Madan R, Sharpe AH, Karp CL, Miaw SC, Ho IC, Kuchroo VK (2009) Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. J Immunol 183(2):797–801. https://doi.org/10.4049/jimmunol.0901233
Powell BR, Buist NR, Stenzel P (1982) An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. J Pediatr 100(5):731–737. https://doi.org/10.1016/s0022-3476(82)80573-8
Prakken B, Ellen W, van Wijk F (2013) Editorial: quality or quantity? Unraveling the role of Treg cells in rheumatoid arthritis. Arthritis Rheum 65(3):552–554. https://doi.org/10.1002/art.37831
Radstake TR, van Bon L, Broen J, Wenink M, Santegoets K, Deng Y, Hussaini A, Simms R, Cruikshank WW, Lafyatis R (2009) Increased frequency and compromised function of T regulatory cells in systemic sclerosis (SSc) is related to a diminished CD69 and TGFbeta expression. PLoS One 4(6):e5981. https://doi.org/10.1371/journal.pone.0005981
Rapetti L, Chavele KM, Evans CM, Ehrenstein MR (2015) B cell resistance to Fas-mediated apoptosis contributes to their ineffective control by regulatory T cells in rheumatoid arthritis. Ann Rheum Dis 74(1):294–302. https://doi.org/10.1136/annrheumdis-2013-204049
Rifa’i M, Kawamoto Y, Nakashima I, Suzuki H (2004) Essential roles of CD8+CD122+ regulatory T cells in the maintenance of T cell homeostasis. J Exp Med 200(9):1123–1134. https://doi.org/10.1084/jem.20040395
Rihs S, Walker C, Virchow JC Jr, Boer C, Kroegel C, Giri SN, Braun RK (1996) Differential expression of alpha E beta 7 integrins on bronchoalveolar lavage T lymphocyte subsets: regulation by alpha 4 beta 1-integrin crosslinking and TGF-beta. Am J Respir Cell Mol Biol 15(5):600–610. https://doi.org/10.1165/ajrcmb.15.5.8918367
Robbins GR, Wen H, Ting JP (2014) Inflammasomes and metabolic disorders: old genes in modern diseases. Mol Cell 54(2):297–308. https://doi.org/10.1016/j.molcel.2014.03.029
Robertson H, Wong WK, Talbot D, Burt AD, Kirby JA (2001) Tubulitis after renal transplantation: demonstration of an association between CD103+ T cells, transforming growth factor beta1 expression and rejection grade. Transplantation 71(2):306–313. https://doi.org/10.1097/00007890-200101270-00024
Roncarolo MG, Gregori S, Bacchetta R, Battaglia M (2014) Tr1 cells and the counter-regulation of immunity: natural mechanisms and therapeutic applications. Curr Top Microbiol Immunol 380:39–68. https://doi.org/10.1007/978-3-662-43492-5_3
Roncarolo MG, Gregori S, Bacchetta R, Battaglia M, Gagliani N (2018) The biology of T regulatory type 1 cells and their therapeutic application in immune-mediated diseases. Immunity 49(6):1004–1019. https://doi.org/10.1016/j.immuni.2018.12.001
Rowe JH, Ertelt JM, Aguilera MN, Farrar MA, Way SS (2011) Foxp3(+) regulatory T cell expansion required for sustaining pregnancy compromises host defense against prenatal bacterial pathogens. Cell Host Microbe 10(1):54–64. https://doi.org/10.1016/j.chom.2011.06.005
Saadoun D, Rosenzwajg M, Joly F, Six A, Carrat F, Thibault V, Sene D, Cacoub P, Klatzmann D (2011) Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis. N Engl J Med 365(22):2067–2077. https://doi.org/10.1056/NEJMoa1105143
Saitoh O, Abiru N, Nakahara M, Nagayama Y (2007) CD8+CD122+ T cells, a newly identified regulatory T subset, negatively regulate Graves’ hyperthyroidism in a murine model. Endocrinology 148(12):6040–6046. https://doi.org/10.1210/en.2007-0300
Sakaguchi S (2004) Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22:531–562. https://doi.org/10.1146/annurev.immunol.21.120601.141122
Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155(3):1151–1164
Sakaguchi S, Vignali DA, Rudensky AY, Niec RE, Waldmann H (2013) The plasticity and stability of regulatory T cells. Nat Rev Immunol 13(6):461–467. https://doi.org/10.1038/nri3464
Samson M, Audia S, Janikashvili N, Ciudad M, Trad M, Fraszczak J, Ornetti P, Maillefert JF, Miossec P, Bonnotte B (2012) Brief report: inhibition of interleukin-6 function corrects Th17/Treg cell imbalance in patients with rheumatoid arthritis. Arthritis Rheum 64(8):2499–2503. https://doi.org/10.1002/art.34477
Santinon F, Batignes M, Mebrek ML, Biton J, Clavel G, Herve R, Lemeiter D, Breckler M, Busato F, Tost J, Ziol M, Boissier MC, Decker P, Semerano L, Bessis N (2019) Involvement of tumor necrosis factor receptor type II in FoxP3 stability and as a marker of Treg cells specifically expanded by anti-tumor necrosis factor treatments in rheumatoid arthritis. Arthritis Rheumatol 72(4):576–587. https://doi.org/10.1002/art.41134
Sarnacki S, Begue B, Buc H, Le Deist F, Cerf-Bensussan N (1992) Enhancement of CD3-induced activation of human intestinal intraepithelial lymphocytes by stimulation of the beta 7-containing integrin defined by HML-1 monoclonal antibody. Eur J Immunol 22(11):2887–2892. https://doi.org/10.1002/eji.1830221120
Sato E, Olson SH, Ahn J, Bundy B, Nishikawa H, Qian F, Jungbluth AA, Frosina D, Gnjatic S, Ambrosone C, Kepner J, Odunsi T, Ritter G, Lele S, Chen YT, Ohtani H, Old LJ, Odunsi K (2005) Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci U S A 102(51):18538–18543. https://doi.org/10.1073/pnas.0509182102
Satoru Todo KY, Goto R, Zaitsu M, Nagatsu A, Oura T, Masaaki W, Takeshi Aoyagi TS, Shimamura T, Kamiyama T, Sato N, Sugita J, Kanako Hatanaka HB, Habu S, Demetris AJ, Ko O (2016) A pilot study of operational tolerance with a regulatory T-Cell-Based cell therapy in living donor liver transplantation. Hepatology 64:2
Scheinecker C, Bonelli M, Smolen JS (2010) Pathogenetic aspects of systemic lupus erythematosus with an emphasis on regulatory T cells. J Autoimmun 35(3):269–275. https://doi.org/10.1016/j.jaut.2010.06.018
Scheinecker C, Goschl L, Bonelli M (2019) Treg cells in health and autoimmune diseases: new insights from single cell analysis. J Autoimmun 110:102376. https://doi.org/10.1016/j.jaut.2019.102376
Scotto L et al (2004) Overlap between molecular markers expressed by naturally occurring CD4+CD25+ regulatory T cells and antigen specific CD4+CD25+ and CD8+CD28- T suppressor cells. Hum Immunol 65(11):1297–1306
Scott-Browne JP, Shafiani S, Tucker-Heard G, Ishida-Tsubota K, Fontenot JD, Rudensky AY, Bevan MJ, Urdahl KB (2007) Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis. J Exp Med 204(9):2159–2169. https://doi.org/10.1084/jem.20062105
Seifert HA, Benedek G, Nguyen H, Kent G, Vandenbark AA, Offner H (2017) Estrogen protects both sexes against EAE by promoting common regulatory cell subtypes independent of endogenous estrogen. Metab Brain Dis 32(5):1747–1754. https://doi.org/10.1007/s11011-017-0063-8
Sempere-Ortells JM, Perez-Garcia V, Marin-Alberca G, Peris-Pertusa A, Benito JM, Marco FM, Zubcoff JJ, Navarro-Blasco FJ (2009) Quantification and phenotype of regulatory T cells in rheumatoid arthritis according to disease activity score-28. Autoimmunity 42(8):636–645. https://doi.org/10.3109/08916930903061491
Serafini G, Andreani M, Testi M, Battarra M, Bontadini A, Biral E, Fleischhauer K, Marktel S, Lucarelli G, Roncarolo MG, Bacchetta R (2009) Type 1 regulatory T cells are associated with persistent split erythroid/lymphoid chimerism after allogeneic hematopoietic stem cell transplantation for thalassemia. Haematologica 94(10):1415–1426. https://doi.org/10.3324/haematol.2008.003129
Shi Z, Rifa’i M, Lee YH, Shiku H, Isobe K, Suzuki H (2008) Importance of CD80/CD86-CD28 interactions in the recognition of target cells by CD8+CD122+ regulatory T cells. Immunology 124(1):121–128. https://doi.org/10.1111/j.1365-2567.2007.02747.x
Shimizu J, Yamazaki S, Takahashi T, Ishida Y, Sakaguchi S (2002) Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 3(2):135–142. https://doi.org/10.1038/ni759
Simon S, Labarriere N (2017) PD-1 expression on tumor-specific T cells: friend or foe for immunotherapy? Onco Targets Ther 7(1):e1364828. https://doi.org/10.1080/2162402x.2017.1364828
Simpson TR, Li F, Montalvo-Ortiz W, Sepulveda MA, Bergerhoff K, Arce F, Roddie C, Henry JY, Yagita H, Wolchok JD, Peggs KS, Ravetch JV, Allison JP, Quezada SA (2013) Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma. J Exp Med 210(9):1695–1710. https://doi.org/10.1084/jem.20130579
Slobodin G, Ahmad MS, Rosner I, Peri R, Rozenbaum M, Kessel A, Toubi E, Odeh M (2010) Regulatory T cells (CD4(+) CD25(bright)FoxP3(+)) expansion in systemic sclerosis correlates with disease activity and severity. Cell Immunol 261(2):77–80. https://doi.org/10.1016/j.cellimm.2009.12.009
Smith TR et al (2009) Dendritic cells use endocytic pathway for cross-priming class Ib MHC-restricted CD8alphaalpha+TCRalphabeta+ T cells with regulatory properties. J Immunol 182(11):6959–6968
Smith TR et al (2010) CD8alpha+ dendritic cells prime TCR-peptide-reactive regulatory CD4+FOXP3- T cells. Eur J Immunol 40(7):1906–1915
Smolen JS, Breedveld FC, Burmester GR, Bykerk V, Dougados M, Emery P, Kvien TK, Navarro-Compan MV, Oliver S, Schoels M, Scholte-Voshaar M, Stamm T, Stoffer M, Takeuchi T, Aletaha D, Andreu JL, Aringer M, Bergman M, Betteridge N, Bijlsma H, Burkhardt H, Cardiel M, Combe B, Durez P, Fonseca JE, Gibofsky A, Gomez-Reino JJ, Graninger W, Hannonen P, Haraoui B, Kouloumas M, Landewe R, Martin-Mola E, Nash P, Ostergaard M, Ostor A, Richards P, Sokka-Isler T, Thorne C, Tzioufas AG, van Vollenhoven R, de Wit M, van der Heijde D (2016) Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis 75(1):3–15. https://doi.org/10.1136/annrheumdis-2015-207524
Solis-Castillo LA, Garcia-Romo GS, Diaz-Rodriguez A, Reyes-Hernandez D, Tellez-Rivera E, Rosales-Garcia VH, Mendez-Cruz AR, Jimenez-Flores JR, Villafana-Vazquez VH, Pedroza-Gonzalez A (2020) Tumor-infiltrating regulatory T cells, CD8/Treg ratio, and cancer stem cells are correlated with lymph node metastasis in patients with early breast cancer. Breast Cancer 27(5):837–849. https://doi.org/10.1007/s12282-020-01079-y
Spaulding C, Guo W, Effros RB (1999) Resistance to apoptosis in human CD8+ T cells that reach replicative senescence after multiple rounds of antigen-specific proliferation. Exp Gerontol 34(5):633–644. https://doi.org/10.1016/s0531-5565(99)00033-9
Speiser DE, Ho PC, Verdeil G (2016) Regulatory circuits of T cell function in cancer. Nat Rev Immunol 16(10):599–611. https://doi.org/10.1038/nri.2016.80
Strioga M, Pasukoniene V, Characiejus D (2011) CD8+ CD28- and CD8+ CD57+ T cells and their role in health and disease. Immunology 134(1):17–32. https://doi.org/10.1111/j.1365-2567.2011.03470.x
Stumhofer JS, Silver JS, Laurence A, Porrett PM, Harris TH, Turka LA, Ernst M, Saris CJ, O’Shea JJ, Hunter CA (2007) Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat Immunol 8(12):1363–1371. https://doi.org/10.1038/ni1537
Su W, Fan H, Chen M, Wang J, Brand D, He X, Quesniaux V, Ryffel B, Zhu L, Liang D, Zheng SG (2012) Induced CD4+ forkhead box protein-positive T cells inhibit mast cell function and established contact hypersensitivity through TGF-β1. J Allergy Clin Immunol 130(2):444–452.e447. https://doi.org/10.1016/j.jaci.2012.05.011
Su W, Chen X, Zhu W, Yu J, Li W, Li Y, Li Z, Olsen N, Liang D, Zheng SG (2019) The cAMP-adenosine feedback loop maintains the suppressive function of regulatory T cells. J Immunol 203(6):1436–1446. https://doi.org/10.4049/jimmunol.1801306
Suciu-Foca N, Manavalan JS, Cortesini R (2003) Generation and function of antigen-specific suppressor and regulatory T cells. Transpl Immunol 11(3–4):235–244. https://doi.org/10.1016/s0966-3274(03)00052-2
Sun Z, Zhong W, Lu X, Shi B, Zhu Y, Chen L, Zhang G, Zhang X (2008) Association of Graves’ disease and prevalence of circulating IFN-gamma-producing CD28(-) T cells. J Clin Immunol 28(5):464–472. https://doi.org/10.1007/s10875-008-9213-4
Sun J, Yang Y, Huo X, Zhu B, Li Z, Jiang X, Xie R, Gao L, Sun Y, Fan H, Zhu Y, Yang J (2019) Efficient therapeutic function and mechanisms of human polyclonal CD8(+)CD103(+)Foxp3(+) regulatory T cells on collagen-induced arthritis in mice. J Immunol Res 2019:8575407. https://doi.org/10.1155/2019/8575407
Suzuki H, Shi Z, Okuno Y, Isobe K (2008) Are CD8+CD122+ cells regulatory T cells or memory T cells? Hum Immunol 69(11):751–754. https://doi.org/10.1016/j.humimm.2008.08.285
Szmyrka-Kaczmarek M, Kosmaczewska A, Ciszak L, Szteblich A, Wiland P (2014) Peripheral blood Th17/Treg imbalance in patients with low-active systemic lupus erythematosus. Postepy Higi Med Dos (Online) 68:893–898. https://doi.org/10.5604/17322693.1111127
Szurek E, Cebula A, Wojciech L, Pietrzak M, Rempala G, Kisielow P, Ignatowicz L (2015) Differences in expression level of helios and neuropilin-1 do not distinguish thymus-derived from extrathymically-induced CD4+Foxp3+ regulatory T cells. PLoS One 10(10):e0141161. https://doi.org/10.1371/journal.pone.0141161
Tanaka A, Sakaguchi S (2017) Regulatory T cells in cancer immunotherapy. Cell Res 27(1):109–118. https://doi.org/10.1038/cr.2016.151
Tang Q, Bluestone JA (2008) The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat Immunol 9(3):239–244. https://doi.org/10.1038/ni1572
Tang Q, Vincenti F (2017) Transplant trials with Tregs: perils and promises. J Clin Invest 127(7):2505–2512. https://doi.org/10.1172/JCI90598
Thiolat A, Semerano L, Pers YM, Biton J, Lemeiter D, Portales P, Quentin J, Jorgensen C, Decker P, Boissier MC, Louis-Plence P, Bessis N (2014) Interleukin-6 receptor blockade enhances CD39+ regulatory T cell development in rheumatoid arthritis and in experimental arthritis. Arthritis Rheumatol 66(2):273–283. https://doi.org/10.1002/art.38246
Thornton AM, Korty PE, Tran DQ, Wohlfert EA, Murray PE, Belkaid Y, Shevach EM (2010) Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J Immunol 184(7):3433–3441. https://doi.org/10.4049/jimmunol.0904028
Todo S, Yamashita K, Goto R, Zaitsu M, Nagatsu A, Oura T, Watanabe M, Aoyagi T, Suzuki T, Shimamura T, Kamiyama T, Sato N, Sugita J, Hatanaka K, Bashuda H, Habu S, Demetris AJ, Okumura K (2016) A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation. Hepatology 64:2. https://doi.org/10.1002/hep.28459/suppinfo
Uss E, Rowshani AT, Hooibrink B, Lardy NM, van Lier RA, ten Berge IJ (2006) CD103 is a marker for alloantigen-induced regulatory CD8+ T cells. J Immunol 177(5):2775–2783. https://doi.org/10.4049/jimmunol.177.5.2775
Vallejo AN (2005) CD28 extinction in human T cells: altered functions and the program of T-cell senescence. Immunol Rev 205:158–169. https://doi.org/10.1111/j.0105-2896.2005.00256.x
Verhagen J, Wraith DC (2010) Comment on “Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells”. J Immunol 185(12):7129.; ; author reply 7130. https://doi.org/10.4049/jimmunol.1090105
Vieira PL, Christensen JR, Minaee S, O’Neill EJ, Barrat FJ, Boonstra A, Barthlott T, Stockinger B, Wraith DC, O’Garra A (2004) IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells. J Immunol 172(10):5986–5993. https://doi.org/10.4049/jimmunol.172.10.5986
Vogt S, Iking-Konert C, Hug F, Andrassy K, Hänsch GM (2003) Shortening of telomeres: evidence for replicative senescence of T cells derived from patients with Wegener’s granulomatosis. Kidney Int 63(6):2144–2151. https://doi.org/10.1046/j.1523-1755.2003.0003.x
von Spee-Mayer C, Siegert E, Abdirama D, Rose A, Klaus A, Alexander T, Enghard P, Sawitzki B, Hiepe F, Radbruch A, Burmester GR, Riemekasten G, Humrich JY (2016) Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus. Ann Rheum Dis 75(7):1407–1415. https://doi.org/10.1136/annrheumdis-2015-207776
Wan N, Dai H, Wang T, Moore Y, Zheng XX, Dai Z (2008) Bystander central memory but not effector memory CD8+ T cells suppress allograft rejection. J Immunol 180(1):113–121. https://doi.org/10.4049/jimmunol.180.1.113
Wang EC, Lawson TM, Vedhara K, Moss PA, Lehner PJ, Borysiewicz LK (1997) CD8high+ (CD57+) T cells in patients with rheumatoid arthritis. Arthritis Rheum 40(2):237–248. https://doi.org/10.1002/art.1780400208
Wang D, Yuan R, Feng Y, El-Asady R, Farber DL, Gress RE, Lucas PJ, Hadley GA (2004) Regulation of CD103 expression by CD8+ T cells responding to renal allografts. J Immunol 172(1):214–221. https://doi.org/10.4049/jimmunol.172.1.214
Wang LX, Li Y, Yang G, Pang PY, Haley D, Walker EB, Urba WJ, Hu HM (2010) CD122+CD8+ Treg suppress vaccine-induced antitumor immune responses in lymphodepleted mice. Eur J Immunol 40(5):1375–1385. https://doi.org/10.1002/eji.200839210
Wang C, Liao Q, Hu Y, Zhong D (2015) T lymphocyte subset imbalances in patients contribute to ankylosing spondylitis. Exp Ther Med 9(1):250–256. https://doi.org/10.3892/etm.2014.2046
Weiss JM, Bilate AM, Gobert M, Ding Y, Curotto de Lafaille MA, Parkhurst CN, Xiong H, Dolpady J, Frey AB, Ruocco MG, Yang Y, Floess S, Huehn J, Oh S, Li MO, Niec RE, Rudensky AY, Dustin ML, Littman DR, Lafaille JJ (2012) Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells. J Exp Med 209(10):1723–1742., , s1721. https://doi.org/10.1084/jem.20120914
Wing JB, Tanaka A, Sakaguchi S (2019) Human FOXP3(+) regulatory T cell heterogeneity and function in autoimmunity and cancer. Immunity 50(2):302–316. https://doi.org/10.1016/j.immuni.2019.01.020
Wood KL, Twigg HL 3rd, Doseff AI (2009) Dysregulation of CD8+ lymphocyte apoptosis, chronic disease, and immune regulation. Front Biosci (Landmark edition) 14:3771–3781. https://doi.org/10.2741/3487
Wu K, Higashi N, Hansen ER, Lund M, Bang K, Thestrup-Pedersen K (2000) Telomerase activity is increased and telomere length shortened in T cells from blood of patients with atopic dermatitis and psoriasis. J Immunol 165(8):4742–4747. https://doi.org/10.4049/jimmunol.165.8.4742
Wu Y, Ren M, Yang R, Liang X, Ma Y, Tang Y, Huang L, Ye J, Chen K, Wang P, Shen H (2011) Reduced immunomodulation potential of bone marrow-derived mesenchymal stem cells induced CCR4+CCR6+ Th/Treg cell subset imbalance in ankylosing spondylitis. Arthritis Res Ther 13(1):R29. https://doi.org/10.1186/ar3257
Wu C, Yosef N, Thalhamer T, Zhu C, Xiao S, Kishi Y, Regev A, Kuchroo VK (2013a) Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature 496(7446):513–517. https://doi.org/10.1038/nature11984
Wu DC, Hester J, Nadig SN, Zhang W, Trzonkowski P, Gray D, Hughes S, Johnson P, Wood KJ (2013b) Ex vivo expanded human regulatory T cells can prolong survival of a human islet allograft in a humanized mouse model. Transplantation 96(8):707–716. https://doi.org/10.1097/TP.0b013e31829fa271
Xu L, Kitani A, Fuss I, Strober W (2007) Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J Immunol 178(11):6725–6729. https://doi.org/10.4049/jimmunol.178.11.6725
Xu A, Liu Y, Chen W, Wang J, Xue Y, Huang F, Rong L, Lin J, Liu D, Yan M, Li QZ, Li B, Song J, Olsen N, Zheng SG (2016) TGF-β-induced regulatory T cells directly suppress B cell responses through a noncytotoxic mechanism. J Immunol 196(9):3631–3641. https://doi.org/10.4049/jimmunol.1501740
Yang S, Wang J, Brand DD, Zheng SG (2018) Role of TNF-TNF receptor 2 signal in regulatory T cells and its therapeutic implications. Front Immunol 9:784. https://doi.org/10.3389/fimmu.2018.00784
Yang M, Liu Y, Mo B, Xue Y, Ye C, Jiang Y, Bi X, Liu M, Wu Y, Wang J, Olsen N, Pan Y, Zheng SG (2019a) Helios but not CD226, TIGIT and Foxp3 is a potential marker for CD4(+) Treg cells in patients with rheumatoid arthritis. Cell Physiol Biochem 52(5):1178–1192. https://doi.org/10.33594/000000080
Yang S, Xie C, Chen Y, Wang J, Chen X, Lu Z, June RR, Zheng SG (2019b) Differential roles of TNFalpha-TNFR1 and TNFalpha-TNFR2 in the differentiation and function of CD4(+) Foxp3(+) induced Treg cells in vitro and in vivo periphery in autoimmune diseases. Cell Death Dis 10(1):27. https://doi.org/10.1038/s41419-018-1266-6
Yao Y, Vent-Schmidt J, McGeough MD, Wong M, Hoffman HM, Steiner TS, Levings MK (2015) Tr1 Cells, but not Foxp3+ regulatory T cells, suppress NLRP3 inflammasome activation via an IL-10-dependent mechanism. J Immunol 195(2):488–497. https://doi.org/10.4049/jimmunol.1403225
Ye L, Goodall JC, Zhang L, Putintseva EV, Lam B, Jiang L, Liu W, Yin J, Lin L, Li T, Wu X, Yeo G, Shugay M, Chudakov DM, Gaston H, Xu H (2016) TCR usage, gene expression and function of two distinct FOXP3(+)Treg subsets within CD4(+)CD25(hi) T cells identified by expression of CD39 and CD45RO. Immunol Cell Biol 94(3):293–305. https://doi.org/10.1038/icb.2015.90
Ye C, Brand D, Zheng SG (2018) Targeting IL-2: an unexpected effect in treating immunological diseases. Signal Transduct Target Ther 3:2. https://doi.org/10.1038/s41392-017-0002-5
Zhang X, Sun S, Hwang I, Tough DF, Sprent J (1998) Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity 8(5):591–599. https://doi.org/10.1016/s1074-7613(00)80564-6
Zhang X, Ouyang X, Xu Z, Chen J, Huang Q, Liu Y, Xu T, Wang J, Olsen N, Xu A, Zheng SG (2019) CD8+CD103+ iTregs inhibit chronic graft-versus-host disease with lupus nephritis by the increased expression of CD39. Mol Ther 27(11):1963–1973. https://doi.org/10.1016/j.ymthe.2019.07.014
Zhao DM, Thornton AM, DiPaolo RJ, Shevach EM (2006) Activated CD4+CD25+ T cells selectively kill B lymphocytes. Blood 107(10):3925–3932. https://doi.org/10.1182/blood-2005-11-4502
Zhao SS, Hu JW, Wang J, Lou XJ, Zhou LL (2011) Inverse correlation between CD4+ CD25high CD127low/- regulatory T-cells and serum immunoglobulin A in patients with new-onset ankylosing spondylitis. J Int Med Res 39(5):1968–1974. https://doi.org/10.1177/147323001103900543
Zhao C, Chu Y, Liang Z, Zhang B, Wang X, Jing X, Hao M, Wang Y, An J, Zhang X, Sun L, Chen J (2019) Low dose of IL-2 combined with rapamycin restores and maintains the long-term balance of Th17/Treg cells in refractory SLE patients. BMC Immunol 20(1):32. https://doi.org/10.1186/s12865-019-0305-0
Zheng SG, Gray JD, Ohtsuka K, Yamagiwa S, Horwitz DA (2002) Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+CD25- precursors. J Immunol 169(8):4183–4189. https://doi.org/10.4049/jimmunol.169.8.4183
Zheng SG, Wang JH, Gray JD, Soucier H, Horwitz DA (2004) Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10. J Immunol 172(9):5213–5221. https://doi.org/10.4049/jimmunol.172.9.5213
Zheng SG, Meng L, Wang JH, Watanabe M, Barr ML, Cramer DV, Gray JD, Horwitz DA (2006) Transfer of regulatory T cells generated ex vivo modifies graft rejection through induction of tolerogenic CD4+CD25+ cells in the recipient. Int Immunol 18(2):279–289. https://doi.org/10.1093/intimm/dxh368
Zheng SG, Wang J, Wang P, Gray JD, Horwitz DA (2007) IL-2 is essential for TGF-beta to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells. J Immunol 178(4):2018–2027. https://doi.org/10.4049/jimmunol.178.4.2018
Zheng SG, Wang J, Horwitz DA (2008) Cutting edge: Foxp3+CD4+CD25+ regulatory T cells induced by IL-2 and TGF-beta are resistant to Th17 conversion by IL-6. J Immunol 180(11):7112–7116. https://doi.org/10.4049/jimmunol.180.11.7112
Zhong H, Liu Y, Xu Z, Liang P, Yang H, Zhang X, Zhao J, Chen J, Fu S, Tang Y, Lv J, Wang J, Olsen N, Xu A, Zheng SG (2018) TGF-beta-induced CD8(+)CD103(+) regulatory T cells show potent therapeutic effect on chronic graft-versus-host disease lupus by suppressing B cells. Front Immunol 9:35. https://doi.org/10.3389/fimmu.2018.00035
Zhou X, Kong N, Wang J, Fan H, Zou H, Horwitz D, Brand D, Liu Z, Zheng SG (2010) Cutting edge: all-trans retinoic acid sustains the stability and function of natural regulatory T cells in an inflammatory milieu. J Immunol 185(5):2675–2679. https://doi.org/10.4049/jimmunol.1000598
Zhou X, Kong N, Zou H, Brand D, Li X, Liu Z, Zheng SG (2011) Therapeutic potential of TGF-beta-induced CD4(+) Foxp3(+) regulatory T cells in autoimmune diseases. Autoimmunity 44(1):43–50. https://doi.org/10.3109/08916931003782163
Zou Y, Xu S, Xiao Y, Qiu Q, Shi M, Wang J, Liang L, Zhan Z, Yang X, Olsen N, Zheng SG, Xu H (2018) Long noncoding RNA LERFS negatively regulates rheumatoid synovial aggression and proliferation. J Clin Invest 128(10):4510–4524. https://doi.org/10.1172/jci97965
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Du, Y., Fang, Q., Zheng, SG. (2021). Regulatory T Cells: Concept, Classification, Phenotype, and Biological Characteristics. In: Zheng, SG. (eds) T Regulatory Cells in Human Health and Diseases. Advances in Experimental Medicine and Biology, vol 1278. Springer, Singapore. https://doi.org/10.1007/978-981-15-6407-9_1
Download citation
DOI: https://doi.org/10.1007/978-981-15-6407-9_1
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-6406-2
Online ISBN: 978-981-15-6407-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)